Delivery Order SPE2DB22D7065-SPE2DB26FH0NC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of UBRELVY 100 mg tablet unit dose packages (10 count). This competitively awarded, non-set-aside contract carries a ceiling value of $3,712.21 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of UBRELVY 100 mg tablets in unit-dose packaging (10 tablets per package). This is a firm fixed-price delivery order valued at $9,494.44, with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets in unit dose packaging (10-count) under a firm fixed-price contract. This award, made on September 25, 2025, carries a ceiling value of $14,145.84 with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units, with a ceiling value of $11,874.35. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and carries no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packages of 10, with a contract ceiling value of $2,361.15 and an ultimate completion date of June 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $3,460.12 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of UBRELVY 50 mg tablets (unit dose, 10s) with an ultimate completion date of October 21, 2025. The contract is non-set-aside and competitively awarded, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of UBRELVY 100 MG tablets in unit dose packaging (10 tablets per unit). This competitively awarded, firm fixed-price delivery order has a ceiling value of $6,583.77 and an ultimate completion date of September 17, 2025. The contract is issued without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the prime contractor, on September 5, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging of 10 count. This is a firm fixed price delivery order with a ceiling value of $8.7K and an ultimate completion date of September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was...
- The Defense Logistics Agency awarded a delivery order valued at $5,663.01 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (16-count unit dose packaging) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order represents a direct fulfillment of pharmaceutical needs under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of UBRELVY 50 mg tablets in unit-dose packaging (10 units per package). This competitive award, valued at $30,906.84, represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB26FH0NCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units. This is a firm fixed price delivery order with a ceiling value of $1,506.23 and an ultimate completion date of October 31, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical supply vehicle enables AmerisourceBergen to fulfill federal medical procurement needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies for military and veteran healthcare systems. The company's track record demonstrates consistent capability in delivering diverse pharmaceutical products to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/30/25 |